Skip to content

The Application and Promotion of Multimodal Integrated Fusion Precision Localization Technology in Epilepsy Surgery

The Application and Promotion of Multimodal Integrated Fusion Precision Localization Technology in Epilepsy Surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129575
Enrollment
Unknown
Registered
2026-08-06
Start date
2026-08-13
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Observation group:None

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Diagnosis of drug-resistant epilepsy: After at least 1 year of standardized treatment with two or more conventional antiepileptic drugs, seizures remain inadequately controlled (>=1 episode per month); 2.Age range 3 to 60 years old, gender not limited; 3.Clinical, electrophysiological, and routine imaging examinations suggest focal epilepsy, requiring precise localization of the epileptic foci and surgical evaluation. 4.Can cooperate to complete multimodal localization examinations (including integrated fusion localization of structural MRI, functional MRI, PET-CT, scalp electroencephalogram, magnetoencephalography, etc.); 5.The patient and legal representative give informed consent and sign a written informed consent form. 6.Good compliance, able to cooperate in completing preoperative evaluation, surgery, and postoperative standardized follow-up.

Exclusion criteria

Exclusion criteria: 1.Severe organic diseases such as heart, liver, kidney, respiratory, and coagulation disorders exist, and preoperative evaluation and surgery are not tolerated; 2.Has severe mental illness and cognitive impairment, unable to cooperate with examination, treatment, and follow-up; 3.Imaging and clinical evaluation suggest diffuse brain lesions and extensive bilateral epileptic foci, which are not suitable for focal precise localization and resection surgery; 4.Merge other neurological diseases that require priority treatment, such as intracranial infections, acute intracranial tumors, and acute cerebrovascular diseases; 5.Pregnant and lactating women; 6.Patients with a history of previous craniotomy surgery, intracranial implants, and other factors that may seriously interfere with multimodal localization results; 7.Simultaneously participating in other clinical trials that may interfere with the observed indicators of this study; 8.Other situations deemed unsuitable for inclusion in this study by the researcher's comprehensive judgment;

Design outcomes

Primary

MeasureTime frame
High frequency EEG tissue transcriptome correlation during surgery;Resection rate of epileptic foci;Positioning accuracy;The preservation status of neurological function;

Secondary

MeasureTime frame
The accuracy, specificity, and clinical utility of multimodal integrated fusion techniques for the precise localization of epileptogenic foci in epilepsy.;

Countries

China

Contacts

Public ContactLi Jinghui

The First Affiliated Hospital of Kunming Medical University

km_ljh@126.com+86 871 65324888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026